Skip to main content
NIH funding notice RFA-AR-19-029

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3 Clinical Trial Required)

Closed on February 26, 2019.

Posted
December 10, 2018
Close date
February 26, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$305,147
$610,294 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. CEDARS-SINAI MEDICAL CENTER1
  2. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1

Most frequent study sections

  1. Special Emphasis Panel (ZAR1 NCB (M1))2
2 awards under RFA-AR-19-029 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2019Randomized-controlled trial of virtual reality for chronic low back pain to improve patient-reported outcomes and physical activity1UG3AR076573-01Spiegel, BrennanCEDARS-SINAI MEDICAL CENTER, CAFirst-year cost $305,895Study section ZAR1
FY2019Proof of concept study to treat negative affect in chronic low back pain1UG3AR076568-01Wasan, Ajay DUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $304,399Study section ZAR1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-AR-19-029: HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3 Clinical Trial Required) | ScienceDex | ConductScience